YYForce Inc. forecasts its fiscal year 2026 revenue to reach $70 million, marking a 22% increase from the $57.2 million recorded in FY2025. This growth is attributed to rising enterprise demand for its AI-enabled Workforce OS platform, expanded robotics deployments, and increased software and service contracts across Southeast Asia. The company plans to leverage its proprietary dispatch software and robotics to enhance cost efficiency and support revenue growth. YYForce remains focused on executing its commercial expansion strategy throughout 2026, backed by positive cash flow and a streamlined capital structure.
YYForce's FY2026 revenue guidance is the focus, with Pluang providing a snapshot of the Technology sector as of Nov 11, 2026 18:02 WIB: among 150 priced US tech stocks, 105 rose and 42 fell. Notable movers include DELL at USD 359.77 (+7.61%), TER at USD 263.79 (+7.49%), and GLW at USD 120.47 (+7.43%), with typical hold times ranging from 39 to 58 days and buy order activity between 58% and 79%.
NRx Pharmaceuticals has begun selling a new preservative-free ketamine made in the U.S., addressing a shortage that has persisted since 2018. This ketamine uses innovative blow-fill-seal technology, eliminating the preservative benzethonium chloride,...
FLSmidth & Co. A/S announced its financial calendar for 2027, including key dates for the annual report, interim financial reports, and the annual general meeting. The company emphasizes its commitment to sustainability with its MissionZero goal to a...
Dimensional Fund Advisors Ltd. has filed a Form 8.3 disclosure revealing it holds a 1.27% stake in Prologis Inc, totaling 12,054,886 shares as of November 10, 2026. This disclosure is part of regulatory requirements under the Takeover Code, indicatin...
Dimensional Fund Advisors Ltd. has filed a disclosure showing it holds a 1.61% stake in DCC Energy plc's ordinary shares as of November 10, 2026. The firm sold 42,998 shares recently at a price of £64.5585 each. This disclosure is part of regulatory ...
Novo Nordisk has committed $200 million to the World Diabetes Foundation for 2027–2036 to enhance diabetes prevention and care in low- and middle-income countries. This funding aims to improve equitable access to diabetes services in underserved comm...
